Mirum Pharmaceuticals (MIRM) Gross Profit (2021 - 2026)
Mirum Pharmaceuticals (MIRM) recorded Gross Profit of $145.9 million in Q2 2026, up 39.8% from $104.36 million a year earlier and up 11.3% from the prior quarter.
Powered by 
Analysis
Mirum Pharmaceuticals (MIRM) Gross Profit (2021 - 2026) Analysis & Trends
On a TTM basis, Mirum Pharmaceuticals' Gross Profit came in at $505.11 million as of Jun 30, 2026, up 48.9% year-over-year; for FY2025, it was $421.07 million, up 65.0% from FY2024.
- Annual Gross Profit has increased for four straight years, with a four-year compound annual growth rate of 122.3% (FY2021 to FY2025).
- Across earlier years, Gross Profit came in at $255.25 million in FY2024 (+83.2%), $139.34 million in FY2023 (+115.4%), $64.69 million in FY2022 (+275.3%) and $17.24 million in FY2021.
- The Q2 2026 figure is the highest quarterly Gross Profit in data going back to Q2 2021.
- On a year-over-year basis, Gross Profit has increased for 14 consecutive quarters, with growth averaging 63.8% over the last eight quarters.
- Across the past five years, year-over-year growth in Gross Profit ran from 36.0% in Q2 2022 to 217.0% in Q3 2022.
- Per Business Quant, the preceding three quarters came in at $131.08 million (Q1 2026), $120.67 million (Q4 2025) and $107.47 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Mirum Pharmaceuticals | 5.37 Bn | 3.79 Bn | 145.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 145.90 Mn |
| Mar 31, 2026 | 131.08 Mn |
| Dec 31, 2025 | 120.67 Mn |
| Sep 30, 2025 | 107.47 Mn |
| Jun 30, 2025 | 104.36 Mn |
| Mar 31, 2025 | 88.57 Mn |
| Dec 31, 2024 | 76.63 Mn |
| Sep 30, 2024 | 69.57 Mn |
| Jun 30, 2024 | 57.65 Mn |
| Mar 31, 2024 | 51.39 Mn |
| Dec 31, 2023 | 44.53 Mn |
| Sep 30, 2023 | 37.50 Mn |
| Jun 30, 2023 | 30.69 Mn |
| Mar 31, 2023 | 26.62 Mn |
| Dec 31, 2022 | 23.41 Mn |
| Sep 30, 2022 | 15.85 Mn |
| Jun 30, 2022 | 14.96 Mn |
| Mar 31, 2022 | 10.47 Mn |
| Dec 31, 2021 | 1.24 Mn |
| Sep 30, 2021 | 5.00 Mn |
API Access
Mirum Pharmaceuticals Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=MIRM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "MIRM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=MIRM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();